Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Janux Therapeutics (JANX) Revenue: 2020-2025

Historic Revenue for Janux Therapeutics (JANX) over the last 4 years, with Sep 2025 value amounting to $10.0 million.

  • Janux Therapeutics' Revenue rose 2177.90% to $10.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.6 million, marking a year-over-year increase of 57.77%. This contributed to the annual value of $10.6 million for FY2024, which is 30.99% up from last year.
  • Latest data reveals that Janux Therapeutics reported Revenue of $10.0 million as of Q3 2025, which was up 2,177.90% from $439,000 recorded in Q3 2024.
  • Over the past 5 years, Janux Therapeutics' Revenue peaked at $10.0 million during Q3 2025, and registered a low of $380,000 during Q1 2021.
  • Moreover, its 3-year median value for Revenue was $2.3 million (2023), whereas its average is $3.6 million.
  • Per our database at Business Quant, Janux Therapeutics' Revenue slumped by 82.56% in 2024 and then soared by 2,177.90% in 2025.
  • Over the past 5 years, Janux Therapeutics' Revenue (Quarterly) stood at $1.6 million in 2021, then soared by 76.05% to $2.8 million in 2022, then dropped by 13.50% to $2.5 million in 2023, then slumped by 82.56% to $439,000 in 2024, then surged by 2,177.90% to $10.0 million in 2025.
  • Its last three reported values are $10.0 million in Q3 2025, $439,000 for Q3 2024, and $8.9 million during Q2 2024.